Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ALT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield 2.38 %
Consecutive Years 0
Forward Annual Dividend 0.097 USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 06.02.2017

Altimmune Inc

ALT
Current price
4.08 USD +0.03 USD (+0.74%)
Last closed 4.05 USD
ISIN US02155H2004
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 328 483 360 USD
Yield for 12 month -35.95 %
1Y
3Y
5Y
10Y
15Y
ALT
21.11.2021 - 28.11.2021

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland. Address: 910 Clopper Road, Gaithersburg, MD, United States, 20878

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

20.63 USD

P/E Ratio

Dividend Yield

Financials ALT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+20 000 USD

Last Year

+426 000 USD

Current Quarter

+5 000 USD

Last Quarter

+5 000 USD

Current Year

+20 000 USD

Last Year

-51 000 USD

Current Quarter

+5 000 USD

Last Quarter

+5 000 USD
EBITDA -98 033 000 USD
Operating Margin TTM -436 300.00 %
Price to Earnings
Return On Assets TTM -35.51 %
PEG Ratio
Return On Equity TTM -57.28 %
Wall Street Target Price 20.63 USD
Revenue TTM 20 000 USD
Book Value 1.83 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -76 546 000 USD
Earnings per share -1.26 USD
Diluted Eps TTM -1.26 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 9 539.41
Price Sales TTM 16 424.17
Enterprise Value EBITDA -4.20
Price Book MRQ 2.38

Technical Indicators ALT

For 52 Weeks

2.90 USD 11.16 USD
50 Day MA 5.58 USD
Shares Short Prior Month 24 400 612
200 Day MA 6.39 USD
Short Ratio 8.05
Shares Short 31 181 920
Short Percent 30.32 %